News
Eloxx Pharmaceuticals
ELOX · OTC
$13.22+$0.72 (+5.76%)TodayMarket closed ·
Prev close $12.50
Latest news
- Press releasePRNewswire
Eloxx Pharmaceuticals Finalizes 52-Week Phase 2 EXPRESS Study Design in Nonsense-Mutation ADPKD and Appoints T.R. Srinivas, M.D., Chief Medical Officer
- Press releasePRNewswire
Eloxx Pharmaceuticals Appoints Biopharmaceutical Industry Veteran Geno Germano to its Board of Directors
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- Press releasePRNewswire
Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- Press releasePRNewswire
Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releasePRNewswire
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq
- Press releaseGlobe Newswire
Eloxx Pharmaceuticals Announces Key Corporate Accomplishments
- Press releaseGlobe Newswire
Eloxx Pharmaceuticals Provides Pipeline and Financing Updates
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.